A noninvasive MRI-based technique, called magnetic resonance spectroscopic imaging (MRSI), could improve the outlook for patients with prostate cancer in whom conventional biopsies have proved fruitless, say US researchers. Rather than sample sections of the prostate gland, as with "gold-standard" biopsies, MRSI enables doctors to check the whole organ for signs of aggressive disease, they say.
MRSI (magnetic resonance spectroscopic imaging) scans find "missed" aggressive prostate cancers
A noninvasive MRI-based technique, called magnetic resonance spectroscopic imaging (MRSI), could improve the outlook for patients with prostate cancer in whom conventional biopsies have proved fruitless, say US researchers. Rather than sample sections of the prostate gland, as with "gold-standard" biopsies, MRSI enables doctors to check the whole organ for signs of aggressive disease, they say.